GlassScriptPhysician profile
Edgar G Miranda
NPI 1487691655
$6,708.65
in general payments reported to CMS, 2019-2025
52 companies · $1,704 in 2025
The $1,704 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $89.37 · 2021: $82.34 · 2022: $425 · 2023: $1,838 · 2024: $2,103 · 2025: $1,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,575 · Education: $70.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,574.62 |
| Education | $70.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $949.30 | 2019-2025 | |
| Gilead Sciences, INC. | $707.05 | 2022-2025 | Trodelvy |
| Pfizer INC. | $574.30 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $317.83 | 2019-2024 | Keytruda, Welireg, Lynparza |
| Incyte Corporation | $266.04 | 2023-2025 | Jakafi, Monjuvi, Zynyz |
| Abbvie INC. | $245.55 | 2020-2025 | |
| Genzyme Corporation | $240.58 | 2021-2025 | |
| Daiichi Sankyo INC. | $219.65 | 2019-2025 | Enhertu, Datroway, Injectafer |
| Inari Medical, INC. | $206.89 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lilly USA, LLC | $193.32 | 2023-2025 | Verzenio, Jaypirca, Retevmo |
| Takeda Pharmaceuticals U.S.A., INC. | $175.64 | 2019-2025 | Alunbrig, Fruzaqla |
| Array Biopharma INC | $162.79 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| Seagen INC. | $148.99 | 2022-2023 | Adcetris, Tukysa, Padcev |
| Regeneron Healthcare Solutions, INC. | $145.33 | 2023-2025 | Libtayo |
| Stryker Corporation | $144.92 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $144.50 | 2022-2024 | Opdivo, Krazati |
| Astellas Pharma US INC | $131.54 | 2021-2025 | Padcev, Xtandi, Xospata |
| Janssen Biotech, INC. | $119.94 | 2019-2025 | Darzalex, Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $106.49 | 2022-2024 | |
| Csl Behring | $104.07 | 2019 | |
| Exelixis INC. | $101.98 | 2023-2024 | Cabometyx |
| Genentech USA, INC. | $97.95 | 2019-2025 | Tecentriq, Phesgo |
| Stemline Therapeutics INC. | $91.68 | 2023-2024 | Orserdu |
| Astrazeneca Pharmaceuticals LP | $84.49 | 2023-2024 | Lynparza, Calquence, Enhertu |
| Puma Biotechnology, INC. | $82.06 | 2022-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $80.09 | 2023 | Imbruvica |
| Eisai INC. | $70.79 | 2023-2024 | |
| Amgen INC. | $69.19 | 2019-2023 | Lumakras |
| Kite Pharma, INC. | $59.82 | 2022-2023 | Yescarta |
| Sumitomo Pharma America, INC. | $53.67 | 2023-2025 | Orgovyx |
| Pharmaessentia USA Corporation | $51.67 | 2023 | Besremi |
| Blueprint Medicines Corporation | $51.52 | 2021-2024 | Ayvakit |
| Servier Pharmaceuticals LLC | $46.44 | 2022-2023 | |
| Jazz Pharmaceuticals INC. | $45.74 | 2022-2023 | |
| Beigene USA, INC. | $41.44 | 2023-2024 | Brukinsa |
| Rigel Pharmaceuticals, INC. | $40.62 | 2024-2025 | Rezlidhia, Tavalisse, Gavreto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.44 | 2023 | Gilotrif |
| Glaxosmithkline, LLC. | $32.17 | 2020-2025 | Ojjaara |
| Dendreon Pharmaceuticals LLC | $27.64 | 2025 | Provenge |
| Alnylam Pharmaceuticals INC. | $23.12 | 2024 | Givlaari |
| Aveo Pharmaceuticals, INC. | $22.39 | 2024 | |
| Sun Pharmaceutical Industries INC. | $21.33 | 2023 | Odomzo, Yonsa |
| Taiho Oncology, INC. | $19.21 | 2024 | |
| Morphosys, US INC. | $18.72 | 2023 | Monjuvi |
| Celgene Corporation | $18.67 | 2024 | Reblozyl |
| Deciphera Pharmaceuticals INC. | $18.54 | 2024 | Qinlock |
| Janssen Pharmaceuticals, INC | $17.39 | 2019 | |
| Agios Pharmaceuticals, INC. | $17.33 | 2025 | Pyrukynd |
| Ipsen Biopharmaceuticals, INC | $17.32 | 2023 | Onivyde, Somatuline Depot |
| Cti Biopharma Corp. | $17.26 | 2023 | Vonjo |
| Sobi, INC | $15.41 | 2023 | |
| Tersera Therapeutics LLC | $13.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Miranda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.